CDEK by Data4ThePeople

Sign in Sign up

← All organizations

INO Therapeutics

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

First marketed drug

First NDA

Last known activity

Dec 23, 1999

Acquired by Ikaria → Mallinckrodt (2013) on Jan 1, 2007

Timeline

1990s

Jan 1, 1998
INO Therapeutics— Founded
Dec 23, 1999
nitric oxide— NDA Organization

2000s

Jan 1, 2007
Ikaria— Acquired By

2010s

Jan 1, 2015
Mallinckrodt (2013)— Now

Indications

Approved for

Hypertension, Pulmonary

Marketed drugs (1)

nitric oxide

Details

Founded: Clinton, NJ, US Jan 1, 1998
First NDA: Dec 23, 1999
Last known activity: Dec 23, 1999

Designations held

Orphan drug
Priority review